Sentence examples for presentation to death from inspiring English sources

The clinical and laboratory information were collected from first presentation to death or until the last available clinical follow-up.

For cancers with short survival, the time from first alarm symptom presentation to relevant cancer diagnosis represents a large part of the overall survival from alarm symptom presentation to death.

Third, the time from clinical presentation to death for affected mongooses is generally short (2 3 months) compared with that for other M. tuberculosis complex pathogens (more chronic infection, can take years to progress to death).

For transplant patients, the median time from first presentation to death was 8.9 years [mean of 9.8 ± 5.1 years], with an average wait of 1.3 ± 0.4 years between first dialysis and transplant.

Overall survival (OS) was measured from date of initial presentation to date of death from any cause (event) or last follow-up (censoring).

Compared to skin IVL, CNS IVL also had a significantly shorter median time from initial presentation of symptoms to death, median time from diagnosis to death, and median time from treatment to death.

Indeed, compared to those without CNS disease, patients with CNS IVL had significantly shorter median time from initial presentation of symptoms to death in 1960 1980s (P = 0.0005), 1990s (P = 0.0002), and 2000s (P = 0.0087).

In 40 patients followed up monthly from presentation until close to death, good agreement was found between doctors and patients on change in specific physical symptoms and overall physical condition.

Compared to nonskin IVL, IVL in the skin had a significantly longer median time from initial presentation of symptoms to death (7.0 [range 0.1 92.0, n = 440] versus 18.0 [range 1.0 110.0, n = 112] months respectively [ P = 0.0001]) but not time from diagnosis to death (P = 0.1372), time from treatment to death (P = 0.2820), or time from treatment to first recurrence (P = 0.7778) (Fig. 8).

Furthermore, the same age effect is also seen with respect to time from initial presentation of symptoms to death (P = 0.0207), time from diagnosis to death (P = 0.0073), and time from treatment to death (P = 0.0502); but not time from treatment to first recurrence (P = 0.7935) (Fig. 4).

In the successive decade analysis of these two organs, there were not enough cases for statistics to be performed in 1960 1980s; but for 1990s and 2000s there was no significance in the time from presentation of symptoms to death, time from diagnosis to death, or time from treatment to death.